In view of the approvals of various COVID-19 vaccines in many countries, Lufthansa Cargo has announced that the cargo carrier is well prepared for their global distribution in the coming months. Air freight is indispensable for the fast and reliable intercontinental distribution of highly sensitive pharmaceuticals. Therefore, a dedicated task force has prepared a variety of possible transport scenarios since spring. “The distribution of temperature- and time-sensitive pharmaceuticals is extremely demanding. We were one of the first airlines to specialise in the transport of medical goods and pharmaceuticals and can therefore draw on many years of experience. Thanks to the recent expansion of our ground infrastructure, we can also handle larger volumes and transport them worldwide while supporting our customers to maintain the cold chain,” explained Peter Gerber, CEO, Lufthansa Cargo. “In 2019, we transported around 100,000 tonnes of pharmaceuticals. We are ready to make another important contribution to overcoming the pandemic by distributing the vaccines worldwide.”
While the transport of COVID-19 vaccines is already available with Lufthansa Cargo the company now announced a premium product to its customers that was specifically developed for the transport of COVID-19 vaccines. The product called COVID-19 Temp Premium will be bookable as of January 11, 2021 and will provide a high level of comprehensive and personalized customer service along the travel chain, including seamless monitoring of vaccine shipments throughout the entire process and a 24/7 after sales support. Additionally, COVID-19 Temp Premium includes high priority capacity access, Lufthansa Cargo’s fastest speed option in combination with temperature focus and a comprehensive security concept as well as bookability throughout the entire Lufthansa Cargo network.
For the transport of pharmaceuticals, three temperature ranges (based on the ambient temperature) are available in airfreight: Controlled Room Temperature for shipments with transport temperature range of +15°C to +25°C, cool storage for shipments with transport temperature range of +2°C to +8°C and deep frozen storage for shipments with transport temperature range of -10°C or below. By using special refrigerated containers and means, such as dry ice, the most diverse requirements of pharmaceutical manufacturers can be met. Accordingly, Lufthansa Cargo also has experience with transports in the ultra-frozen range (-70°C).
The specific packaging, transport, handling and storage requirements of the various COVID-19 vaccines, and the quantities to be transported, by which routes and over which periods of time, are partly still open. The actual transport routes of the vaccines depend largely on the future production sites for approved vaccines and the respective recipient markets. With its current freighter fleet of 18 aircraft, Lufthansa Cargo can respond flexibly to shifts in demand. If necessary, the provision of additional belly capacity can also be examined.
As a carrier, Lufthansa Cargo provides its customers with capacity for transporting goods from airport to airport. The carrier uses the global network of its own freighter aircraft as well as the flights of Lufthansa, Austrian Airlines, Brussels Airlines and Eurowings that are open for cargo. Clients consist of air freight forwarding companies.